| :: |
| :: |
| :: |
| :: |
| :: |
| :: |
| :: |
| :: |
| :: |
| :: |
| :: |
|
|
Date |
Speaker |
Title |
|
September 5, 2003 |
Suzanne AW Fuqua, Ph.D.,
Baylor College of Medicine |
Role of estrogen receptors
alpha and beta in breast cancer |
|
October 3, 2003 |
Susan Weller, Ph.D., UTMB |
Validation of diabetes mellitus screening guidelines |
|
November 7, 2003 |
Janet E. Price, D.Phil.,
UT M.D. Anderson Cancer Center |
Experimental models of breast cancer metastasis |
|
December 5, 2003 |
D. Mark Estes, Ph.D., and Edward M. Curran, Ph.D. |
The impact of estrogen receptor signaling on immunity to
infection and cancer |
|
January 16, 2004 |
Ellen Gritz, Ph.D., UT M.D. Anderson
Cancer Center |
Women and Smoking: Myths and Controversies |
|
February 6, 2004 |
Daniel Medina,
Ph.D., Baylor College of Medicine |
Hormone-mediated prevention and hormone
dependence of premalignant mammary progression |
|
March 5, 2004 |
Diane C. Bodurka, M.D., M.P.H., UT M.D.
Anderson Cancer Center |
Update on
ovarian cancer: What you need to know |
|
April 2, 2004 |
Jan Blalock, Ph.D., UT M.D. Anderson
Cancer Center |
Evaluating a mood management smoking
cessation intervention for pregnant smokers |
|
May 7, 2004 |
Shilla Chakrabarty, Ph.D., and Gayle
Weaver, Ph.D., UTMB |
Chakrabarty: “Effect of performance enhancing drugs on
the female reproductive system”
and
Weaver: “Coping Well with Systemic Lupus
Erythematosus: Is the Health Care System a Help or Hindrance? - The
Boston Group” |
|